Haoyu Wu
-
- Blood Pressure and Hypertension Studies 2
- Heart Failure Treatment and Management 2
-
- Lipoproteins and Cardiovascular Health 4
-
- Adenosine and Purinergic Signaling 3
-
- Metabolomics and Mass Spectrometry Studies 2
- Genomics, phytochemicals, and oxidative stress 2
- Peroxisome Proliferator-Activated Receptors 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 2
Haoyu Wu
33 papers receiving 453 citations
Peers
Comparison fields: 5 of 91
- Health, Toxicology and Mutagenesis 53
- Cancer Research 46
- Biological Psychiatry 7
- Cardiology and Cardiovascular Medicine 59
- Genetics 71
Countries citing papers authored by Haoyu Wu
This map shows the geographic impact of Haoyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haoyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haoyu Wu more than expected).
Fields of papers citing papers by Haoyu Wu
This network shows the impact of papers produced by Haoyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haoyu Wu. The network helps show where Haoyu Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Haoyu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 14 | |
| 7 | 2023 | 15 | |
| 8 | 2022 | 22 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 30 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 21 | |
| 15 | 2021 | 3 | |
| 16 | 2021 | 21 | |
| 17 | 2021 | 18 | |
| 18 | 2020 | 43 | |
| 19 | 2018 | 24 | |
| 20 | 2015 | 33 |
About Haoyu Wu
Haoyu Wu is a scholar working on Physiology, Aging and Geriatrics and Gerontology, having authored 36 papers that have together received 458 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (4 papers), Adenosine and Purinergic Signaling (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Blood Pressure and Hypertension Studies (2 papers), Heart Failure Treatment and Management (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (53 citations), Cancer Research (46 citations) and Biological Psychiatry (7 citations). Haoyu Wu has collaborated with scholars based in China, United Kingdom and Canada. Frequent co-authors include Kun Ma, Bai‐Xiang Li, Vincenzo Forgetta, J. Brent Richards, Peng Li, Sirui Zhou, Bowen Lou, Celia M.T. Greenwood, Tianyuan Lu and Zuyi Yuan. Their work appears in journals such as Circulation Research, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.